These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26379435)

  • 1. Different patterns of nuclear and mitochondrial penetration by the G3 PAMAM dendrimer and its biotin-pyridoxal bioconjugate BC-PAMAM in normal and cancer cells in vitro.
    Uram Ł; Szuster M; Filipowicz A; Gargasz K; Wołowiec S; Wałajtys-Rode E
    Int J Nanomedicine; 2015; 10():5647-61. PubMed ID: 26379435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cytotoxicity of the ternary PAMAM G3-pyridoxal-biotin bioconjugate.
    Uram Ł; Szuster M; Gargasz K; Filipowicz A; Wałajtys-Rode E; Wołowiec S
    Int J Nanomedicine; 2013; 8():4707-20. PubMed ID: 24376351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of G3 PAMAM dendrimer conjugated with B-group vitamins on cell morphology, motility and ATP level in normal and cancer cells.
    Uram Ł; Szuster M; Misiorek M; Filipowicz A; Wołowiec S; Wałajtys-Rode E
    Eur J Pharm Sci; 2017 May; 102():275-283. PubMed ID: 28323116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
    Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
    Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the localization and biological effects of PAMAM G3 dendrimer-biotin/pyridoxal conjugate as HaCaT keratinocyte targeted nanocarrier.
    Szuster M; Uram ŁS; Filipowicz-Rachwał A; Wołowiec S; Wałajtys-Rode E
    Acta Biochim Pol; 2019 Apr; 66(2):191-200. PubMed ID: 30964128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines.
    Uram Ł; Filipowicz A; Misiorek M; Pieńkowska N; Markowicz J; Wałajtys-Rode E; Wołowiec S
    Eur J Pharm Sci; 2018 Nov; 124():1-9. PubMed ID: 30118847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Different Effects of Biotinylated PAMAM G3 Dendrimer Substituted with Nimesulide in Human Normal Fibroblasts and Squamous Carcinoma Cells.
    Uram Ł; Filipowicz-Rachwał A; Misiorek M; Winiarz A; Wałajtys-Rode E; Wołowiec S
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and
    Markowicz J; Uram Ł; Wołowiec S; Rode W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Absorption-Enhancement and the Mechanism of the PAMAM Dendrimer on Poorly Absorbable Drugs.
    Lu J; Li N; Gao Y; Li N; Guo Y; Liu H; Chen X; Zhu C; Dong Z; Yamamoto A
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30103462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro.
    Uram Ł; Misiorek M; Pichla M; Filipowicz-Rachwał A; Markowicz J; Wołowiec S; Wałajtys-Rode E
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity.
    Shao N; Su Y; Hu J; Zhang J; Zhang H; Cheng Y
    Int J Nanomedicine; 2011; 6():3361-72. PubMed ID: 22267921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
    Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
    J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed-Generation PAMAM G3-G0 Megamer as a Drug Delivery System for Nimesulide: Antitumor Activity of the Conjugate Against Human Squamous Carcinoma and Glioblastoma Cells.
    Zaręba M; Sareło P; Kopaczyńska M; Białońska A; Uram Ł; Walczak M; Aebisher D; Wołowiec S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31601050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotin-Containing Third Generation Glucoheptoamidated Polyamidoamine Dendrimer for 5-Aminolevulinic Acid Delivery System.
    Kaczorowska A; Malinga-Drozd M; Kałas W; Kopaczyńska M; Wołowiec S; Borowska K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.
    Intra J; Salem AK
    J Pharm Sci; 2010 Jan; 99(1):368-84. PubMed ID: 19670295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
    Dong Z; Katsumi H; Sakane T; Yamamoto A
    Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
    Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified PAMAM dendrimer with 4-carbomethoxypyrrolidone surface groups-its uptake, efflux, and location in a cell.
    Janaszewska A; Studzian M; Petersen JF; Ficker M; Paolucci V; Christensen JB; Tomalia DA; Klajnert-Maculewicz B
    Colloids Surf B Biointerfaces; 2017 Nov; 159():211-216. PubMed ID: 28797971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
    Goldberg DS; Vijayalakshmi N; Swaan PW; Ghandehari H
    J Control Release; 2011 Mar; 150(3):318-25. PubMed ID: 21115079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
    Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
    Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.